ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.365,53
-0,82%
S&P 500
5.319,11
-0,04%
US Dollar vs BRL
5,1453
0,43%
Bitcoin
70.349,08
0,31%
Brent Oil
82,255
-0,23%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. AMAG Pharmaceuticals Inc (AMAG)

  7. AMAG Pharmaceuticals Inc (AMAG) Notícias

AMAG

AMAG Pharmaceuticals (AMAG)

AMAG Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMAG
DataHoraFonteTítuloCódigoCompanhia
16/02/202118:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/12/202010:47GlobeNewswire Inc.AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/11/202011:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202008:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202008:01Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202017:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202008:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202018:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202018:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202011:27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202011:25PR Newswire (US)Covis Group Completes Acquisition of AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
13/11/202010:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/11/202018:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMAGAMAG Pharmaceuticals Inc
05/11/202020:40PR Newswire (US)MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCa...NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202009:44Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202008:30PR Newswire (Canada)Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202008:23Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/10/202017:11GlobeNewswire Inc.AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for...NASDAQ:AMAGAMAG Pharmaceuticals Inc
13/10/202017:37Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
05/10/202022:05GlobeNewswire Inc.AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)NASDAQ:AMAGAMAG Pharmaceuticals Inc
02/10/202014:02PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202018:21Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202011:45GlobeNewswire Inc.Covis Group Announces Agreement to Acquire AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202018:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202017:07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
09/09/202009:00GlobeNewswire Inc.AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:AMAGAMAG Pharmaceuticals Inc
06/08/202008:00GlobeNewswire Inc.AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:AMAGAMAG Pharmaceuticals Inc
28/07/202009:00GlobeNewswire Inc.AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 202...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/07/202008:30GlobeNewswire Inc.AMAG Pharmaceuticals Completes Divestment of Women’s Health AssetsNASDAQ:AMAGAMAG Pharmaceuticals Inc
23/07/202010:01PR Newswire (US)AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Austr...NASDAQ:AMAGAMAG Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMAG

Seu Histórico Recente

USOTC
SGGKY
Singapore Tech Engineering (PK)
BIT
I09333
Intesa Sanpaolo
BIT
PA0863
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados